6 research outputs found

    On the Effect of Correlation on the Capacity of Backscatter Communication Systems

    Full text link
    We analyse the effect of correlation between the forward and backward links on the capacity of backscatter communication systems. To that aim, we obtain an analytical expression for the average capacity under a correlated Rayleigh product fading channel, as well as closed-form asymptotic expressions for the high and low signal-to-noise ratio (SNR) regimes. Our results show that correlation is indeed detrimental for a fixed target SNR; contrarily to the common belief, we also see that correlation can be actually beneficial in some instances when a fixed power budget is considered.Comment: This work has been submitted for publication. Copyright may be transferred without notice, after which this version may no longer be accessibl

    Effect of Correlation between Information and Energy Links in Secure Wireless Powered Communications

    No full text
    In this paper, we investigate the impact of correlation between the energy and information links in wireless power transfer systems, from a physical layer security perspective. With that aim, we first determine how correlation can affect system capacity in practical energy harvesting set-ups in the absence of eavesdroppers. We quantify that even though link correlation improves the average signal-to-noise ratio (SNR) for a fixed transmit power, it also increases its variance, which ultimately degrades capacity. Based on this observation, we show that correlation between the energy and information links may be detrimental/beneficial for the secrecy capacity in the high/low legitimate SNR regime, whenever such correlation affects the legitimate user. Conversely, we also point out that when link correlation for the wiretap link is rigorously accounted for, it barely affects secrecy performance, causing only a minor degradation in some instances.Comment: This work has been submitted to the IEEE for possible publication. Copyright may be transferred without notice, after which this version may no longer be accessibl

    Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000

    No full text
    SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

    No full text

    Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

    No full text
    Background: The extent to which the prognosis for AIDS and death of patients initiating highly active antiretroviral therapy (HAART) continues to be affected by their characteristics at the time of initiation (baseline) is unclear. Methods: We analyzed data on 20,379 treatment-naive HIV-1- infected adults who started HAART in 1 of 12 cohort studies in Europe and North America (61,798 person-years of follow-up, 1844 AIDS events, and 1005 deaths). Results: Although baseline CD4 cell count became less prognostic with time, individuals with a baseline CD4 count 350 cells/μL (hazard ratio for AIDS = 2.3, 95% confidence interval [CI]: 1.0 to 2.3; mortality hazard ratio = 2.5, 95% CI: 1.2 to 5.5, 4 to 6 years after starting HAART). Rates of AIDS were persistently higher in individuals who had experienced an AIDS event before starting HAART. Individuals with presumed transmission by means of injection drug use experienced substantially higher rates of AIDS and death than other individuals throughout follow-up (AIDS hazard ratio = 1.6, 95% CI: 0.8 to 3.0; mortality hazard ratio = 3.5, 95% CI: 2.2 to 5.5, 4 to 6 years after starting HAART). Conclusions: Compared with other patient groups, injection drug users and patients with advanced immunodeficiency at baseline experience substantially increased rates of AIDS and death up to 6 years after starting HAART

    Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

    No full text
    Background. We obtained estimates of the incidence of tuberculosis (TB) among patients receiving HAART and identified determinants of the incidence. Methods. We analyzed the incidence of TB during the first 3 years after initiation of HAART among 17,142 treatment-naive, AIDS- free persons starting HAART who were enrolled in 12 cohorts from Europe and North America. We used univariable and multivariable Poisson regression models to identify factors associated with the incidence. Results. During the first 3 years (36,906 person-years), 173 patients developed TB (incidence, 4.69 cases per 1000 person-years). In multivariable analysis, the incidence rate was lower for men who have sex with men, compared with injection drug users (relative rate, 2.46; 95% confidence interval [CI], 1.51-4.01), heterosexuals (relative rate, 2.42; 95% CI, 1.64-3.59), those with other suspected modes of transmission (relative rate, 1.66; 95% CI, 0.91-3.06), and those with a higher CD4(+) count at the time of HAART initiation (relative rate per log(2) cells/mL, 0.87; 95% CI, 0.84-0.91). During 28,846 person-years of follow-up after the first 6 months of HAART, 88 patients developed TB (incidence, 3.1 cases per 1000 person-years of follow-up). In multivariable analyses, a low baseline CD4(+) count (relative rate per log(2) cells/mL, 0.89; 95% CI, 0.83-0.96), 6-month CD4(+) count (relative rate per log(2) cells/mL, 0.90; 95% CI, 0.81-0.99), and a 6-month HIV RNA level 1400 copies/mL (relative rate, 2.21; 95% CI, 1.33-3.67) were significantly associated with the risk of acquiring TB after 6 months of HAART. Conclusion. The level of immunodeficiency at which HAART is initiated and the response to HAART are important determinants of the risk of TB. However, this risk remains appreciable even among those with a good response to HAART, suggesting that other interventions may be needed to control the TB epidemic in the HIV-infected population
    corecore